Lauder Focuses On Millennials In Turnaround Of Namesake, Clinique
This article was originally published in The Rose Sheet
Firm expects to record modest gains for its Estee Lauder and Clinique brands in fiscal 2016, after slight declines projected for both in the current fiscal year, and is innovating for and engaging with millennials to drive momentum. During Lauder's recent third-quarter earnings call, leadership highlighted forthcoming product launches expected to appeal to the younger generation while continuing to serve core consumers.
You may also be interested in...
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.
Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.